Culver joined HEP in 2023. Prior to joining the team, Culver was an analyst on Oppenheimer & Co.’s Healthcare Investment Banking team, at which he focused on M&A and capital markets advisory services for the biopharma, medtech, and healthcare services sectors. Before Oppenheimer, Culver was a consultant for Trinity Life Sciences, focused on strategic advisory and market research for healthcare companies.